[go: up one dir, main page]

AU2003298827A1 - Methods for preparing antigen masked red blood cells having reduced hemolysis by sera - Google Patents

Methods for preparing antigen masked red blood cells having reduced hemolysis by sera

Info

Publication number
AU2003298827A1
AU2003298827A1 AU2003298827A AU2003298827A AU2003298827A1 AU 2003298827 A1 AU2003298827 A1 AU 2003298827A1 AU 2003298827 A AU2003298827 A AU 2003298827A AU 2003298827 A AU2003298827 A AU 2003298827A AU 2003298827 A1 AU2003298827 A1 AU 2003298827A1
Authority
AU
Australia
Prior art keywords
sera
methods
blood cells
red blood
preparing antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003298827A
Other versions
AU2003298827A8 (en
Inventor
Shruti Mathur
Adonis Stassinopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cerus Corp
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Publication of AU2003298827A1 publication Critical patent/AU2003298827A1/en
Publication of AU2003298827A8 publication Critical patent/AU2003298827A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2003298827A 2002-12-04 2003-12-03 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera Abandoned AU2003298827A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US43121302P 2002-12-04 2002-12-04
US43121602P 2002-12-04 2002-12-04
US43121502P 2002-12-04 2002-12-04
US43121402P 2002-12-04 2002-12-04
US60/431,216 2002-12-04
US60/431,214 2002-12-04
US60/431,215 2002-12-04
US60/431,213 2002-12-04
PCT/US2003/038349 WO2004050897A2 (en) 2002-12-04 2003-12-03 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera

Publications (2)

Publication Number Publication Date
AU2003298827A1 true AU2003298827A1 (en) 2004-06-23
AU2003298827A8 AU2003298827A8 (en) 2004-06-23

Family

ID=32475715

Family Applications (4)

Application Number Title Priority Date Filing Date
AU2003298827A Abandoned AU2003298827A1 (en) 2002-12-04 2003-12-03 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera
AU2003297614A Abandoned AU2003297614A1 (en) 2002-12-04 2003-12-03 Novel activated polyethylene glycol compounds
AU2003293237A Abandoned AU2003293237A1 (en) 2002-12-04 2003-12-03 Methods for reacting an antigen masking compound with red blood cells with high efficiency
AU2003302499A Abandoned AU2003302499A1 (en) 2002-12-04 2003-12-03 Methods for antigen masking of red blood cells resulting in reduced hemolysis

Family Applications After (3)

Application Number Title Priority Date Filing Date
AU2003297614A Abandoned AU2003297614A1 (en) 2002-12-04 2003-12-03 Novel activated polyethylene glycol compounds
AU2003293237A Abandoned AU2003293237A1 (en) 2002-12-04 2003-12-03 Methods for reacting an antigen masking compound with red blood cells with high efficiency
AU2003302499A Abandoned AU2003302499A1 (en) 2002-12-04 2003-12-03 Methods for antigen masking of red blood cells resulting in reduced hemolysis

Country Status (2)

Country Link
AU (4) AU2003298827A1 (en)
WO (4) WO2004050848A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521174B2 (en) * 2003-12-05 2009-04-21 Albert Einstein College Of Medicine Of Yeshiva University Universal red blood cells, methods of preparing same, and uses thereof
CN102108119A (en) 2009-12-25 2011-06-29 天津键凯科技有限公司 Multi-arm polyethylene glycol derivatives and their conjugates and gels with drugs
EA201890149A1 (en) 2015-06-26 2018-07-31 Сирус Корпорейшн COMPOSITIONS OF CRYOPRECIPLES AND METHODS OF THEIR RECEPTION
US10799533B2 (en) 2015-10-23 2020-10-13 Cerus Corporation Plasma compositions and methods of use thereof
AU2017382449B2 (en) 2016-12-23 2024-10-24 Cerus Corporation Systems and methods for testing and screening using compound bound substrates
BR112019018273A2 (en) 2017-03-03 2020-07-14 Cerus Corporation kits and methods for preparing pathogen inactivated platelet compositions
TWI821233B (en) 2017-12-29 2023-11-11 美商西勒斯股份有限公司 Methods for treating biological fluids, pathogen inactivated biological fluids prepared by the methods, and systems for treating biological fluids
CA3143213A1 (en) 2019-06-22 2020-12-30 Cerus Corporation Biological fluid treatment systems
WO2020264421A1 (en) 2019-06-28 2020-12-30 Cerus Corporation System and methods for implementing a biological fluid treatment device
MX2024010825A (en) * 2022-03-07 2024-09-17 Icoat Medical Ab New use of peg-phospholipid molecules.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL292906A (en) * 1962-10-30
US6312685B1 (en) * 1998-03-13 2001-11-06 Timothy C. Fisher Red blood cells covalently bound with two different polyethylene glycol derivatives
US20020042043A1 (en) * 2000-05-31 2002-04-11 Adonis Stassinopoulos Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity

Also Published As

Publication number Publication date
WO2004050848A2 (en) 2004-06-17
AU2003293237A8 (en) 2004-06-23
WO2004049914A2 (en) 2004-06-17
AU2003293237A1 (en) 2004-06-23
AU2003297614A8 (en) 2004-06-23
WO2004050029A3 (en) 2004-10-21
WO2004050029A2 (en) 2004-06-17
AU2003302499A8 (en) 2004-06-23
AU2003297614A1 (en) 2004-06-23
WO2004050897A3 (en) 2004-08-26
AU2003302499A1 (en) 2004-06-23
AU2003298827A8 (en) 2004-06-23
WO2004049914A3 (en) 2005-02-24
WO2004050897A2 (en) 2004-06-17
WO2004050848A3 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
AU2003234608A1 (en) Automated dialysis system
IL174460A0 (en) Fully human antibodies against human 4-ibb (cd137)
AU2002357049A1 (en) Methods for preparing 0-desmethylvenlafaxine
AU2003225160A1 (en) "biosensor for dialysis therapy"
AU2002322518A1 (en) Methods for preparing nucleic acid samples
AU2002340641A1 (en) Methods for assembling protein microarrays
AU2003281175A1 (en) Method for examination about peritoneal function
AU2003262094A1 (en) Cancer antigen peptide preparation
AU2002355230A1 (en) Blood dialyzer
AU2003298827A1 (en) Methods for preparing antigen masked red blood cells having reduced hemolysis by sera
AU2003227728A1 (en) Anti-dandruff shampoos
AU2002339305A1 (en) Method for purifying full blood
AU2002950611A0 (en) Blood flow analysis system
AU2003261353A1 (en) High density reagent array preparation methods
AU2003286843A1 (en) Process for preparing hybrid proteins
AU2002257064A1 (en) Methods for isolating proteins expressed by dendritic cells
EP1341467A4 (en) Method for precipitating red blood cells
AU2003218007A1 (en) Methods for purifying selected cea family member proteins
AU2003294206A1 (en) Methods for diagnosing htlv-i-mediated diseases
AU2002302410A1 (en) Method for identifying immune reactive epitopes on proteins
AU2002354943A1 (en) Haptenizing cancer cell components for the preparation of cancer vaccines
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2003223192A1 (en) Proteins for helicobacter diagnosis
AU2003284212A1 (en) Process for the preparation of (s,s)-cis-2-phenyl-3-aminopiperidine
AU2003906928A0 (en) Cyclospora Antibodies

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase